Trends and emerging technologies in extracorporeal life support: results of the 2006 ECLS survey.
Extracorporeal life support (ECLS) is a procedure used to support the failing heart and/or lungs via a heart lung machine. Over 145 institutions perform this practice in the United States with more than 24,000 ECLS cases recorded. While many articles are published each year on common perfusion practice, little information is shared on emerging technologies in ECLS and common practices among perfusionists and ECLS specialists. This article presents our 2006 ECLS survey results and discusses emerging technologies and management topics new to the ECLS arena. ECLS specialists were asked to participate in an online survey. Two hundred twenty-two ECLS specialists responded. This survey suggests positive displacement roller pumps are still the leading pump used for ECLS 122/188 (64.9%). Silicone membrane oxygenators are used by responders 75% of the time for long-term use, while hollow fiber membrane oxygenators are used 44%. Forty-five percent of responders are using heparin or biocoated circuits exclusively, while 14.6% restrict their use to specific subpopulations. The most common coating is heparin coating (67.9%). Activated clotting time (ACT) management is still standard of care for coagulation monitoring (98%), while partial thromboplastin time (PTT) follows at 71.7%. The interquartile range for ACTs is 160-220 seconds and 160-200 seconds with active bleeding. This article suggests ECLS specialists are beginning to incorporate different technology into their practice, such as centrifugal pumps with hollow fiber oxygenators and coated-circuits.
Sievert
Alicia N
AN
Cardiovascular Perfusion Program, College of Health Professions, Medical University of South Carolina, 151B Rutledge Ave., PO Box 250964, Charleston, SC 29425, USA. sievera@musc.edu
Shackelford
Anthony G
AG
McCall
Mary M
MM
D005112:Extracorporeal Circulation / Q000295:instrumentation / Q000639:trends*; D019538:Health Care Surveys; D006353:Heart-Assist Devices; D006801:Humans; D010106:Oxygenators; D014481:United States
Ann Thorac Surg. 1994 Aug;58(2):541-2
8067860
Ann Thorac Surg. 1992 Apr;53(4):553-63
1554261
ASAIO J. 2000 May-Jun;46(3):319-22
10826744
ASAIO J. 2003 Jul-Aug;49(4):395-400
12918580
Perfusion. 1990;5(3):193-201
10149489
Hosp Pract (Off Ed). 1984 Apr;19(4):139-43, 146, 151
6425311
Ann Thorac Surg. 1997 Jan;63(1):105-11
8993250
Perfusion. 2005 May;20(3):129-34
16038383
J Thorac Cardiovasc Surg. 1995 Jul;110(1):46-54
7609568
Ann Thorac Surg. 2001 Mar;71(3):922-7; discussion 927-8
11269475
Artif Organs. 2000 Aug;24(8):618-23
10971248
J Extra Corpor Technol. 2005 Dec;37(4):351-4
16524150
Perfusion. 2004 Jan;19(1):17-23
15072251
J Extra Corpor Technol. 2004 Mar;36(1):16-21
15095836
Trans Am Soc Artif Intern Organs. 1976;22:80-93
951895
Clin Chem. 2001 May;47(5):858-66
11325889
N Engl J Med. 1972 Mar 23;286(12):629-34
5060491
ASAIO J. 2005 Sep-Oct;51(5):508-12
16322707
J Artif Organs. 2005;8(1):41-6
15951979
Ann Surg. 1986 Sep;204(3):236-45
3530151
Ann Thorac Surg. 2004 Mar;77(3):932-41
14992902
Ann Thorac Surg. 2004 May;77(5):1678-83
15111165
Ann Thorac Surg. 1999 Aug;68(2):513-20
10475421
ASAIO J. 2006 Jan-Feb;52(1):110-4
16436900
J Thorac Cardiovasc Surg. 1998 Aug;116(2):305-11
9699584
Arch Surg. 2000 Sep;135(9):1042-7
10982508
Surgery. 1993 Aug;114(2):161-72; discussion 172-3
8342122
Ann Thorac Surg. 2003 Dec;76(6):S2224-9
14667691
J Thorac Cardiovasc Surg. 1975 May;69(5):685-9
1127967